RRM1 and Miyoshi myopathy: Early promising results were found in different MM cell lines using an RRM1 inhibitor didox (3,4-dihydroxybenzohydroxamic acid)27; however, several studies have shown the possible interaction of didox with additional targets aside from RRM128.